Rezolute’s stock has plunged 87%…
Rezolute’s stock has plunged 87% after the company’s rare disease [...]
Eli Lilly has surpassed…
Eli Lilly has surpassed analysts’ highest hopes for the efficacy [...]
Moderna has tapped Swedish…
Moderna has tapped Swedish long-acting drug formulation company Nanexa to [...]
Barreling toward the end of its…
Barreling toward the end of its cash runway, GRI Bio [...]
OTR may still be keeping its own…
OTR may still be keeping its own pipeline under wraps, [...]
Two affiliates of Apple Tree…
Two affiliates of Apple Tree Partners have filed for bankruptcy, [...]
People come to Orlando to escape….
People come to Orlando to escape. With Disney World, SeaWorld [...]
Exicure’s investigational small…
Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells [...]
Ose Immunotherapeutics is…
Ose Immunotherapeutics is prioritizing its lung cancer med Tedopi and [...]
Pfizer’s recent bidding war for…
Pfizer’s recent bidding war for an obesity biotech clearly hasn’t [...]